The SEQC2 epigenomics quality control (EpiQC) study
Authors:
Open Access
- 6 December 2021
- journal article
- research article
- Published by Springer Nature in Genome Biology
- Vol. 22 (1) , 1-30
Abstract
Background: Cytosine modifications in DNA such as 5-methylcytosine (5mC) underlie a broad range of developmental processes, maintain cellular lineage specification, and can define or stratify types of cancer and other diseases. However, the wide variety of approaches available to interrogate these modifications has created a need for harmonized materials, methods, and rigorous benchmarking to improve genome-wide methylome sequencing applications in clinical and basic research. Here, we present a multi-platform assessment and cross-validated resource for epigenetics research from the FDA’s Epigenomics Quality Control Group.Results: Each sample is processed in multiple replicates by three whole-genome bisulfite sequencing (WGBS) protocols (TruSeq DNA methylation, Accel-NGS MethylSeq, and SPLAT), oxidative bisulfite sequencing (TrueMethyl), enzymatic deamination method (EMSeq), targeted methylation sequencing (Illumina Methyl Capture EPIC), single-molecule long-read nanopore sequencing from Oxford Nanopore Technologies, and 850k Illumina methylation arrays. After rigorous quality assessment and comparison to Illumina EPIC methylation microarrays and testing on a range of algorithms (Bismark, BitmapperBS, bwa-meth, and BitMapperBS), we find overall high concordance between assays, but also differences in efficiency of read mapping, CpG capture, coverage, and platform performance, and variable performance across 26 microarray normalization algorithms.Conclusions: The data provided herein can guide the use of these DNA reference materials in epigenomics research, as well as provide best practices for experimental design in future studies. By leveraging seven human cell lines that are designated as publicly available reference materials, these data can be used as a baseline to advance epigenomics research.Keywords
Funding Information
- Horizon 2020 (824110-EASI-Genomics)
- National Institutes of Health (5P30GM114737, P20GM103466, U54 MD007584, 2U54MD007601, S10OD019960)
- American Health Assistance Foundation (18IPA34170301)
This publication has 40 references indexed in Scilit:
- The Cancer Genome Atlas Pan-Cancer analysis projectNature Genetics, 2013
- A data-driven approach to preprocessing Illumina 450K methylation array dataBMC Genomics, 2013
- DNA methylation: roles in mammalian developmentNature Reviews Genetics, 2013
- SWAN: Subset-quantile Within Array Normalization for Illumina Infinium HumanMethylation450 BeadChipsGenome Biology, 2012
- Complete Pipeline for Infinium ® Human Methylation 450K BeadChip Data Processing Using Subset Quantile Normalization for Accurate DNA Methylation EstimationEpigenomics, 2012
- Amplification-free whole-genome bisulfite sequencing by post-bisulfite adaptor taggingNucleic Acids Research, 2012
- Evaluation of the Infinium Methylation 450K technologyEpigenomics, 2011
- The NIH Roadmap Epigenomics Mapping ConsortiumNature Biotechnology, 2010
- A statistical method for excluding non-variable CpG sites in high-throughput DNA methylation profilingBMC Bioinformatics, 2010
- DNA methylation and human diseaseNature Reviews Genetics, 2005